Clinical Trial Update: Efficacy and Safety of TMZ Plus CDDP in the Patients With Recurrent Malignant Gliomas [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the combination of temozolomide and cisplatin in patients with recurrent malignant gliomas, reporting on efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Gliomas

Drugs mentioned

• Platinol (cisplatin)
• Temodar (Temozolomide)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Malignant Gliomas | Phase 2 | Status: UNKNOWN